Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: ABL, Beyondspring, Celltrion Healthcare, Cstone, Deciphera, Eisai, Everest Medicines, Evive, I-Mab, Innovent Biologics, JCR, Jemincare, Lannett, Moderna, Neurophth, Opthea, Ose Immunotherapeutics, Respirent, Russian Direct Investment Fund, SK, Tetra, Zai Lab.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Antengene, Bioniz, Gan & Lee, Huyabio, Landos, Mitoimmune, Ortho Regenerative, Tarus.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Electrocore, Orthofix, Surgical Information Sciences, Vysioneer.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 89bio, Abbvie, Acadia, Exelixis, Eli Lilly, Passage, Supernus, Tetra.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Nano-X Imaging, Quidel.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Jemincare, Kite, Moderna, Ose, Regeneron, Tetra.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Becton Dickinson, Bluestar Genomics, Inspire.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Autolus, Beyondspring, Lannett, Moderna, Neurophth, Respirent, Sanofi, Secura, Taiho, United.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dialco Medical, Neuropace, Oxehealth, Premia Spine.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Affimed, Amryt, Celltrion, Cstone, CTI, Everest, Evive, Exelixis, Innovent, Ipsen, Jazz, Mabxience, Nkmax, Opthea, Provention, SK, Surface Oncology, Syndax, Zai.